12 completed. 12 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 12 |
| Phase 2 | 3 | Completed 3 |
Follow prucalopride: new trials by email Literature Review of prucalopride trials Research Report on prucalopride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients Prucalopride, Metoclopramide - Enteral Feeding Intolerance | Phase 1 / Phase 2 | Completed | Ain Shams University | 70 | 2022-08-30 | 2024-04-12 |
| Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial Prucalopride, Buspirone, Placebo - Dyspepsia | Phase 1 / Phase 2 | Completed | Universidade de Passo Fundo | 1 | 2022-01-06 | 2022-05-17 |
| Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation YH12852 IR 0.05mg, YH12852 IR 0.1mg, YH12852 IR 0.3mg - Functional Constipation | Phase 1 / Phase 2 | Completed | Yuhan Corporation | 120 | 2015-08-01 | 2016-10-31 |
| Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects YH12852, Prucalopride, Placebo - Healthy | Phase 1 | Completed | Yuhan Corporation | 127 | 2013-08-01 | 2015-05-08 |
| Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment prucalopride - Hepatic Impairment | Phase 1 | Completed | Movetis | 24 | 2010-05-01 | 2012-04-19 |
| M0001 Effects on Oral Contraceptive Plasma Levels prucalopride - Healthy Volunteers | Phase 1 | Completed | Movetis | 16 | 2009-12-01 | 2011-05-17 |
| Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters prucalopride, moxifloxacin, placebo - Constipation | Phase 1 | Completed | Movetis | 120 | 2009-01-01 | 2009-05-18 |
| A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride prucalopride, Placebo - Constipation | Phase 1 | Completed | Movetis | 32 | 2000-01-01 | 2008-05-29 |
| Prucalopride in Paediatric Subjects, With Functional Faecal Retention prucalopride - Constipation | Phase 1 | Completed | Movetis | 37 | 1998-11-01 | 2012-08-22 |
| Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention prucalopride - Constipation | Phase 1 | Completed | Movetis | 38 | 1998-11-01 | 2012-08-28 |
| Prucalopride Subjects With Renal Impairment prucalopride - Constipation | Phase 1 | Completed | Movetis | 34 | 1997-07-01 | 2012-08-28 |
| Safety Study of Prucalopride in Healthy Volunteers Prucalopride, Placebo - Healthy | Phase 1 | Completed | Movetis | 2008-11-21 |
Constipation (5) · Dyspepsia (1)
Movetis (8) · Yuhan Corporation (2) · Ain Shams University (1) · Universidade de Passo Fundo (1)
South Korea (2) · Brazil (1) · Egypt (1) · Germany (1) · Russia (1)
Harald Winter, M.D. (2) · Eman Elmokadem, PhD (1) · Fernando Fornari (1) · Howard Lee, MD, PhD (1) · M J Boyce, M.D. (1) · Remi VD Broeck, MD (1) · W. Smith, M.D. (1)
PMID 23535761, PMID 21848574, PMID 23269861, PMID 23539257, PMID 39584139